Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Cytomegalovirus, Epstein-Barr virus and varicella zoster virus infection in the first two years of life: a cohort study in Bradford, UK

Authors: Lucy Pembrey, Dagmar Waiblinger, Paul Griffiths, Mauli Patel, Rafaq Azad, John Wright

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Cytomegalovirus (CMV), Epstein Barr virus (EBV) and varicella-zoster virus (VZV) are common herpesviruses frequently acquired in childhood, which establish persistent, latent infection and are likely to impact the developing immune system. Little is known about the epidemiology of CMV and EBV infections in contemporary UK paediatric populations, particularly whether age at infection differs by ethnic group.

Methods

Children enrolled in the Born in Bradford Allergy and Infection Study had a blood sample taken and a questionnaire completed at 12 and 24 months of age. Ordered logistic regression quantified associations between ethnicity and other risk factors and age at CMV/EBV/VZV infection (<12 months, 12–24 months, uninfected at 24 months).

Results

Pakistani children (n = 472) were more likely to be infected with CMV and EBV at a younger age than White British children (n = 391) (CMV: adjusted odds ratio (OR) 2.53, 95% confidence interval (CI) 1.47–4.33; EBV: adjusted OR 2.16, 95% CI 1.43–3.26). Conversely, Pakistani children had lower odds of being VZV infected in the second year than White British children (adjusted OR 0.57, 95% CI 0.33–0.97). There was a strong association between increasing birth order and later CMV infection in Pakistani children.

Conclusions

We report large differences in CMV and EBV incidence in the first 2 years between Pakistani and White British children born in Bradford, which cannot be explained by differences in risk factors for infection. Our data will inform the optimum schedule for future CMV and EBV vaccination programmes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Miles DJ, van der Sande M, Jeffries D, Kaye S, Ojuola O, Sanneh M, Cox M, Palmero MS, Touray ES, Waight P, et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One. 2008;3(8):e2905.CrossRefPubMedPubMedCentral Miles DJ, van der Sande M, Jeffries D, Kaye S, Ojuola O, Sanneh M, Cox M, Palmero MS, Touray ES, Waight P, et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One. 2008;3(8):e2905.CrossRefPubMedPubMedCentral
2.
go back to reference Holder B, Miles DJ, Kaye S, Crozier S, Mohammed NI, Duah NO, Roberts E, Ojuola O, Palmero MS, Touray ES, et al. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. PLoS One. 2010;5(11):e14013.CrossRefPubMedPubMedCentral Holder B, Miles DJ, Kaye S, Crozier S, Mohammed NI, Duah NO, Roberts E, Ojuola O, Palmero MS, Touray ES, et al. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. PLoS One. 2010;5(11):e14013.CrossRefPubMedPubMedCentral
3.
go back to reference Leray E, Moreau T, Fromont A, Edan G, Epidemiology of multiple sclerosis. Rev Neurol. 2016;172(1):3–13. Leray E, Moreau T, Fromont A, Edan G, Epidemiology of multiple sclerosis. Rev Neurol. 2016;172(1):3–13.
4.
go back to reference Cohen JI, Fauci AS, Varmus H, Nabel GJ. Epstein-Barr virus: an important vaccine target for cancer prevention. Sci Transl Med. 2011;3(107):107fs.CrossRef Cohen JI, Fauci AS, Varmus H, Nabel GJ. Epstein-Barr virus: an important vaccine target for cancer prevention. Sci Transl Med. 2011;3(107):107fs.CrossRef
5.
go back to reference Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011;6(2):e16103.CrossRefPubMedPubMedCentral Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011;6(2):e16103.CrossRefPubMedPubMedCentral
6.
7.
go back to reference Purssell E. Shingles vaccination: background and advice for community nurses. Br J Community Nurs. 2014;19(9):442–6.CrossRefPubMed Purssell E. Shingles vaccination: background and advice for community nurses. Br J Community Nurs. 2014;19(9):442–6.CrossRefPubMed
8.
go back to reference Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2012;12(4):290–9.CrossRefPubMed Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2012;12(4):290–9.CrossRefPubMed
9.
go back to reference Griffiths PD. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis. 2012;12(10):790–8.CrossRefPubMed Griffiths PD. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis. 2012;12(10):790–8.CrossRefPubMed
10.
go back to reference Cohen JI. Epstein-barr virus vaccines. Clin Translational Immunol. 2015;4(1):e32.CrossRef Cohen JI. Epstein-barr virus vaccines. Clin Translational Immunol. 2015;4(1):e32.CrossRef
11.
go back to reference Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Carroll MD, Dollard SC. Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012. Clin Vaccine Immunol. 2015;22(2):245–7.CrossRefPubMedPubMedCentral Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Carroll MD, Dollard SC. Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012. Clin Vaccine Immunol. 2015;22(2):245–7.CrossRefPubMedPubMedCentral
12.
go back to reference Wright J, Small N, Raynor P, Tuffnell D, Bhopal R, Cameron N, Fairley L, Lawlor DA, Parslow R, Petherick ES, et al. Cohort Profile: The Born in Bradford multi-ethnic family cohort study. Int J Epidemiol. 2013;42(4):978–91.CrossRefPubMed Wright J, Small N, Raynor P, Tuffnell D, Bhopal R, Cameron N, Fairley L, Lawlor DA, Parslow R, Petherick ES, et al. Cohort Profile: The Born in Bradford multi-ethnic family cohort study. Int J Epidemiol. 2013;42(4):978–91.CrossRefPubMed
13.
go back to reference Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013;8(11):e81881.CrossRefPubMedPubMedCentral Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013;8(11):e81881.CrossRefPubMedPubMedCentral
14.
go back to reference Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed. 2008;93(4):F280–285.CrossRefPubMed Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed. 2008;93(4):F280–285.CrossRefPubMed
17.
go back to reference Schleiss MR. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Rev Med Virol. 2006;16(2):73–82.CrossRefPubMed Schleiss MR. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Rev Med Virol. 2006;16(2):73–82.CrossRefPubMed
18.
go back to reference Manikkavasagan G, Dezateux C, Wade A, Bedford H. The epidemiology of chickenpox in UK 5-year olds: an analysis to inform vaccine policy. Vaccine. 2010;28(48):7699–705.CrossRefPubMed Manikkavasagan G, Dezateux C, Wade A, Bedford H. The epidemiology of chickenpox in UK 5-year olds: an analysis to inform vaccine policy. Vaccine. 2010;28(48):7699–705.CrossRefPubMed
19.
go back to reference Ma X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL, Reynolds P. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2002;86(9):1419–24.CrossRefPubMedPubMedCentral Ma X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL, Reynolds P. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2002;86(9):1419–24.CrossRefPubMedPubMedCentral
20.
go back to reference Harding NJ, Birch JM, Hepworth SJ, McKinney PA. Infectious exposure in the first year of life and risk of central nervous system tumors in children: analysis of day care, social contact, and overcrowding. Cancer Causes Control. 2009;20(2):129–36.CrossRefPubMed Harding NJ, Birch JM, Hepworth SJ, McKinney PA. Infectious exposure in the first year of life and risk of central nervous system tumors in children: analysis of day care, social contact, and overcrowding. Cancer Causes Control. 2009;20(2):129–36.CrossRefPubMed
21.
go back to reference Crowcroft NS, Vyse A, Brown DW, Strachan DP. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. J Epidemiol Community Health. 1998;52(2):101–4.CrossRefPubMedPubMedCentral Crowcroft NS, Vyse A, Brown DW, Strachan DP. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. J Epidemiol Community Health. 1998;52(2):101–4.CrossRefPubMedPubMedCentral
22.
go back to reference Balfour Jr HH, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208(8):1286–93.CrossRefPubMed Balfour Jr HH, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208(8):1286–93.CrossRefPubMed
23.
go back to reference StataCorp. Stata Statistical Software: Release 13. College Station: StataCorp LP; 2013. StataCorp. Stata Statistical Software: Release 13. College Station: StataCorp LP; 2013.
24.
go back to reference Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect. 2004;132(6):1129–34.CrossRefPubMedPubMedCentral Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect. 2004;132(6):1129–34.CrossRefPubMedPubMedCentral
25.
go back to reference Talukder YS, Kafatos G, Pinot de Moira A, Aquilina J, Parker SP, Crowcroft NS, Brown DW, Breuer J. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect. 2007;135(8):1344–53.CrossRefPubMedPubMedCentral Talukder YS, Kafatos G, Pinot de Moira A, Aquilina J, Parker SP, Crowcroft NS, Brown DW, Breuer J. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect. 2007;135(8):1344–53.CrossRefPubMedPubMedCentral
26.
go back to reference Sinha DP. Chickenpox--a disease predominantly affecting adults in rural West Bengal, India. Int J Epidemiol. 1976;5(4):367–74.CrossRefPubMed Sinha DP. Chickenpox--a disease predominantly affecting adults in rural West Bengal, India. Int J Epidemiol. 1976;5(4):367–74.CrossRefPubMed
27.
go back to reference Korndewal MJ, Mollema L, Tcherniaeva I, van der Klis F, Kroes AC, Oudesluys-Murphy AM, Vossen AC, de Melker HE. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53–8.CrossRefPubMed Korndewal MJ, Mollema L, Tcherniaeva I, van der Klis F, Kroes AC, Oudesluys-Murphy AM, Vossen AC, de Melker HE. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53–8.CrossRefPubMed
28.
go back to reference Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert L. National serosurvey of cytomegalovirus in Australia. Clin Vaccine Immunol. 2006;13(11):1181–4.CrossRefPubMedPubMedCentral Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert L. National serosurvey of cytomegalovirus in Australia. Clin Vaccine Immunol. 2006;13(11):1181–4.CrossRefPubMedPubMedCentral
29.
go back to reference Nilsson C, Linde A, Montgomery SM, Gustafsson L, Nasman P, Blomberg MT, Lilja G. Does early EBV infection protect against IgE sensitization? J Allergy Clin Immunol. 2005;116(2):438–44.CrossRefPubMed Nilsson C, Linde A, Montgomery SM, Gustafsson L, Nasman P, Blomberg MT, Lilja G. Does early EBV infection protect against IgE sensitization? J Allergy Clin Immunol. 2005;116(2):438–44.CrossRefPubMed
30.
go back to reference Dowd JB, Zajacova A, Aiello A. Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children. Soc Sci Med. 2009;68(4):699–707.CrossRefPubMedPubMedCentral Dowd JB, Zajacova A, Aiello A. Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children. Soc Sci Med. 2009;68(4):699–707.CrossRefPubMedPubMedCentral
31.
go back to reference O’Brien TP, Thompson JM, Black PN, Becroft DM, Clark PM, Robinson E, Wild C, Mitchell EA. Prevalence and determinants of cytomegalovirus infection in pre-school children. J Paediatr Child Health. 2009;45(5):291–6.CrossRefPubMed O’Brien TP, Thompson JM, Black PN, Becroft DM, Clark PM, Robinson E, Wild C, Mitchell EA. Prevalence and determinants of cytomegalovirus infection in pre-school children. J Paediatr Child Health. 2009;45(5):291–6.CrossRefPubMed
32.
go back to reference Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, Fraaij PL, van Zelm MC, Moll HA: Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood. J Pediatrics. 2016;170:126–34. Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, Fraaij PL, van Zelm MC, Moll HA: Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood. J Pediatrics. 2016;170:126–34.
33.
go back to reference Bernsen RM, Nagelkerke NJ, al-Ramadi BK. Does paternal antigen-induced secretion of interleukin-10 by T regulatory cells mediate the birth order effect? Med Hypotheses. 2006;67(4):740–3.CrossRefPubMed Bernsen RM, Nagelkerke NJ, al-Ramadi BK. Does paternal antigen-induced secretion of interleukin-10 by T regulatory cells mediate the birth order effect? Med Hypotheses. 2006;67(4):740–3.CrossRefPubMed
34.
go back to reference Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O’Beirne J, et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet. 2011;377(9773):1256–63.CrossRefPubMedPubMedCentral Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O’Beirne J, et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet. 2011;377(9773):1256–63.CrossRefPubMedPubMedCentral
35.
go back to reference Sabbaj S, Pass RF, Goepfert PA, Pichon S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis. 2011;203(11):1534–41.CrossRefPubMedPubMedCentral Sabbaj S, Pass RF, Goepfert PA, Pichon S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis. 2011;203(11):1534–41.CrossRefPubMedPubMedCentral
36.
go back to reference Gibbs S, Surridge H, Adamson R, Cohen B, Bentham G, Reading R. Atopic dermatitis and the hygiene hypothesis: a case-control study. Int J Epidemiol. 2004;33(1):199–207.CrossRefPubMed Gibbs S, Surridge H, Adamson R, Cohen B, Bentham G, Reading R. Atopic dermatitis and the hygiene hypothesis: a case-control study. Int J Epidemiol. 2004;33(1):199–207.CrossRefPubMed
37.
go back to reference Morris MC, Edmunds WJ, Hesketh LM, Vyse AJ, Miller E, Morgan-Capner P, Brown DW. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol. 2002;67(4):522–7.CrossRefPubMed Morris MC, Edmunds WJ, Hesketh LM, Vyse AJ, Miller E, Morgan-Capner P, Brown DW. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol. 2002;67(4):522–7.CrossRefPubMed
38.
go back to reference Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB. Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study. Schizophr Res. 2014;158(1-3):19–24.CrossRefPubMedPubMedCentral Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB. Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study. Schizophr Res. 2014;158(1-3):19–24.CrossRefPubMedPubMedCentral
39.
go back to reference Condon LM, Cederberg LE, Rabinovitch MD, Liebo RV, Go JC, Delaney AS, Schmeling DO, Thomas W, Balfour Jr HH. Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment. Clin Infect Dis. 2014;59(4):501–8.CrossRefPubMed Condon LM, Cederberg LE, Rabinovitch MD, Liebo RV, Go JC, Delaney AS, Schmeling DO, Thomas W, Balfour Jr HH. Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment. Clin Infect Dis. 2014;59(4):501–8.CrossRefPubMed
40.
go back to reference Goodier MR, White MJ, Darboe A, Nielsen CM, Goncalves A, Bottomley C, Moore SE, Riley EM. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood. 2014;124(14):2213–22.CrossRefPubMedPubMedCentral Goodier MR, White MJ, Darboe A, Nielsen CM, Goncalves A, Bottomley C, Moore SE, Riley EM. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood. 2014;124(14):2213–22.CrossRefPubMedPubMedCentral
41.
go back to reference Rostgaard K, Wohlfahrt J, Hjalgrim H. A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark. Clin Infect Dis. 2014;58(12):1684–9.CrossRefPubMed Rostgaard K, Wohlfahrt J, Hjalgrim H. A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark. Clin Infect Dis. 2014;58(12):1684–9.CrossRefPubMed
42.
go back to reference Sidorchuk A, Wickman M, Pershagen G, Lagarde F, Linde A. Cytomegalovirus infection and development of allergic diseases in early childhood: interaction with EBV infection? J Allergy Clin Immunol. 2004;114(6):1434–40.CrossRefPubMed Sidorchuk A, Wickman M, Pershagen G, Lagarde F, Linde A. Cytomegalovirus infection and development of allergic diseases in early childhood: interaction with EBV infection? J Allergy Clin Immunol. 2004;114(6):1434–40.CrossRefPubMed
43.
go back to reference Saghafian-Hedengren S, Sverremark-Ekstrom E, Linde A, Lilja G, Nilsson C. Early-life EBV infection protects against persistent IgE sensitization. J Allergy Clin Immunol. 2010;125(2):433–8.CrossRefPubMed Saghafian-Hedengren S, Sverremark-Ekstrom E, Linde A, Lilja G, Nilsson C. Early-life EBV infection protects against persistent IgE sensitization. J Allergy Clin Immunol. 2010;125(2):433–8.CrossRefPubMed
Metadata
Title
Cytomegalovirus, Epstein-Barr virus and varicella zoster virus infection in the first two years of life: a cohort study in Bradford, UK
Authors
Lucy Pembrey
Dagmar Waiblinger
Paul Griffiths
Mauli Patel
Rafaq Azad
John Wright
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2319-7

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue